Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

Opioid related deaths in Norway in 2000-2019

The aim of the study is to present autopsy-based findings of the most prevalent opioids in overdose deaths in Norway from 2000 to 2019

Original research | 2022

Overdose, Mortality, Safer supply, About PWUD, Outcomes, Illegal drugs

Police discretion in encounters with people who use drugs: operationalizing the theory of planned behavior

This study deploys the Theory of Planned Behavior (TPB) to understand what influences police intentions to make discretionary referrals to treatment and harm reduction resources rather than arrest on

Original research | 2021

Social services, Legal system/law enforcement, Illegal drugs, Transitions in care/treatment, Stigma

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison

Examine during- and post-prison outcomes among people prescribed OAT

Commentary | 2022

Harm reduction, Wrap-around services, About PWUD, Social services, Outcomes, Crime, Legal system/law enforcement, Substitution/OAT

Toxicology and prescribed medication histories among people experiencing fatal illicit drug overdose in British Columbia, Canada

Our objective was to assess prescription history in the context of postmortem toxicology among people who had a fatal illicit drug overdose in BC.

Original research | 2020

Overdose, Mortality, Evidence base, Safer supply, Outcomes, Illegal drugs, Stimulants

Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings

This study assessed the safety of subcutaneous slow-release depot buprenorphine in custody.

Original research | 2022

Outcomes, Legal system/law enforcement, Substitution/OAT, Diversion

Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study

The aim of this work was to understand (1) the perspectives of family physicians (FPs) as it relates to opioid prescribing, and (2) the perceived barriers and enablers to guideline-adherent opioid pre

Original research | 2019

Clinical guidance, Policy/Regulatory, Hesitancy of prescribers , Safer supply, About prescribers, Barriers and enablers, Chronic pain

A Treatment Algorithm for Attention Deficit Hyperactivity Disorder in Cocaine-Dependent Adults: A One-Year Private Practice Study with Long-Acting Stimulants, Fluoxetine, and Bupropion

We report evidence that study subjects probably medicated their ADHD symptoms with cocaine and describe a 1‐year treatment algorithm featuring long‐acting stimulants that was effective in the manageme

Original research | 1999

About prescribers, Outcomes, Illegal drugs, Stimulants

Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019

Cannabis legalization in many jurisdictions worldwide has raised concerns that such legislation might increase the burden of transient and persistent psychotic illnesses in society.

Original research | 2022

Policy/Regulatory, Mental health

Crystal Meth, Opiates, Overdose and Housing in Kingston, Ontario: 2021 Rapid Assessment and Reponse

The people who frequent the Integrated Care Hub (ICH) – its stakeholders – know best what they are experiencing and what they need.

Report | 2021

Overdose, Evidence base, Harm reduction, Policy/Regulatory, Wrap-around services, Safer supply, Decriminalization/legalization, Equity, About PWUD, Social services, Barriers and enablers, Poverty, Housing, Crime, Legal system/law enforcement, Illegal drugs, Chronic pain, Indigenous, Small/medium cities, Stimulants, Sex/Gender , Stigma, Mental health

Drug Overdose Mortality by Race/Ethnicity across US-Born and Immigrant Populations

Examined racial/ethnic differences in US drug overdose mortality among US-born and foreign-born men and women.

Original research | 2022

Overdose, Mortality, Equity, Illegal drugs

Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness

During a COVID-19 outbreak in the congregate shelter system in Halifax, Nova Scotia, Canada, a multidisciplinary health care team provided an emergency “safe supply” of pharmaceutical-grade medicat

Original research | 2022

Harm reduction, Policy/Regulatory, Safer supply, About PWUD, Social services, Outcomes, Poverty, Housing, Small/medium cities

Getting to Tomorrow

Video | 2020

Overdose, Mortality, Policy/Regulatory, Decriminalization/legalization, Equity, Advocacy, About prescribers, About PWUD, Illegal drugs

Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study

This study explores the experiences of adults receiving extended-release buprenorphine (XRB) as a jail-to-community treatment.

Original research | 2022

About PWUD, Barriers and enablers, Legal system/law enforcement, Substitution/OAT

Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment

This study examines the relationship between hospital-based or initiated OUD services and the racial/ethnic composition of the surrounding community.

Original research | 2022

Equity, About PWUD, Illegal drugs, Substitution/OAT, Transitions in care/treatment, Hospitals

Safer Crack Smoking

Handout | 2020

Harm reduction, Illegal drugs, Stimulants

Safer Crystal Meth Smoking

Handout | 2020

Harm reduction, Illegal drugs, Stimulants

Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury

Traumatic injury frequently requires opioid analgesia to manage pain and avoid catastrophic complications. Risk screening for opioid misuse and the development of use disorder remains uninvestigated

Original research | 2022

Harm reduction, Hesitancy of prescribers , About PWUD, Outcomes, Chronic pain, Mental health, Hospitals

The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealt

This study investigated the efficacy and safety of providing medication for opioid use disorder (MOUD) and individualized telehealth in Kentucky, a state severely impacted simultaneously by the opioid

Original research | 2022

About PWUD, Barriers and enablers, Outcomes, Poverty, Housing, Illegal drugs, Substitution/OAT, Digital health

The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study

In 2012, Spain adopted new legislation on opioid prescription (the ROE law), which meant that practitioners no longer needed to obtain extra authorisation in order to prescribe strong opioids.

Original research | 2021

Evidence base, Policy/Regulatory, Safer supply, About prescribers, Outcomes